Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

American Journal of Clinical Pathology

Volumn 105, Issue 4, 1996, Pages 394-402

  Siitonen, Sanna M ^a   Kononen, Juha T ^b   Helin, Heikki J ^a   Rantala, Immo S ^a   Holli, Kaija A ^a   Isola, Jorma J ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Breast cancer; Cell cell adhesion; Malignancy; Metastasis; Patient outcome

Indexed keywords

UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029926185     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.4.394     Document Type: Article

References (40)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-1455.
2. Eidelman S, Damsky CH, Wheelock MJ, Damjanov I. Expression of the cell-cell adhesion glycoprotein Cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol 1989;135:101-110.
3. Shimoyama Y, Hirohashi S, Hirano S, et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989;49:2128-2133.
4. Birchmeier W, Behrens J. Cadherin expression in carcinomas: Role in the formation of cell junctions and prevention of invasiveness. Biochim Biophys Acta 1994;1198:11-26.
5. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989;108:2435-2447.
6. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cell. J Cell Biol 1991;113:173-185.
7. Vleminckx K. Vakaet L, Marcel M, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. J Cell Biol 1991;66:107-119.
8. Shiozaki H, Tahara H, Oka H, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991;139:17-23.
9. Schipper JH, Frixen UH, Behrens J, et al. E-cadherin expression in squamous cell carcinomas of head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991;51:6328-6337.
10. Dorudi S, Sheffield JP, Poulsom R, Northover JMA, Hart IR. E-cadherin expression in colorectal cancer An immunohistochemical and in situ hybridization study. Am J Pathol 1993;142:981-986.
11. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54:3929-3933.
12. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and gladular disintegration. Cancer Res 1993;53:1690-1695.
13. Sakuragi N, Nishiya M, Ikeda K, et al. E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol 1994;53: 183-189.
14. Kadowaki T, Shiozaki H, Inoue M, et al. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 1994;54: 291-296.
15. Mattijssen V, Peters HM, Schalkwijk L, et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 1993;55:580-585.
16. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993;143:1-12.
17. Gamallo C, Palacios H, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142:987-993.
18. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissue and its relationship to metastasis. Cancer Res 1993;53:1696-1701.
19. Bringuier PP, Umbas R, Schaafsma HE, et al. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993;53:3241-3245.
20. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjänen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994;174:101-109.
21. Rasbridge SA, Gillet CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993;169:245-250.
22. Hartmann WH, Ozzello L, Sobin LH, et al, eds. Histological typing of breast tumors. ed 2. Geneva, Switzerland: World Health Organization, 1981.
23. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-377.
24. Peacock CS, Thompson IW, van Norden S. Silver enhancement of polymerized diaminobenzidine: Increased sensitivity for immunoperoxidase staining. J Clin Pathol 1991;44:156-158.
25. Sommers CL, Thompson EW, Torri JA, et al. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: Relationship to morphology and invasive capacities. Cell Growth Differ 1991;2:365-372.
26. Dagerlind Å, Friberg K, Bean AJ, Hökfelt T. Sensitive messenger RNA detection using unfixed tissue: Combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 1992;98:39-49.
27. Rimm DL, Morrow JS. Molecular cloning of human E-cadherin suggests a novel subdivision of the cadherin superfamily. Biochem Biophys Res Commun 1994;200:1754-1761.
28. Kallioniemi O-P. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry. Cytometry 1988;9:164-169.
29. Helin HJ, Helle MJ, Helin ML, Isola JJ. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers. Am J Clin Pathol 1988;89:137-142.
30. Kallioniemi O-P, Holli K, Visakorpi T, et al. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 1991;49:650-655.
31. Dixon WJ. BMDP Statistical Software. Los Angeles: University of California Press, 1981.
32. Sato T, Tanigami A, Yamakawa K, et al. Allelotype of breast cancer: Cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990;50:7184-7189.
33. Carter BS, Ewing CM, Ward WS, et al. Allelic loss of chromosome 16q and 10q in human prostate cancer. Proc Natl Acad Sci 1990;87:8751-8755.
34. Tsuda H, Zhang W, Shimosato Y, et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci 1990;87:6791-6794.
35. Behrens J, Löwrick O, Klein-Hitpass L, Birchmeier W. The E-cadherin promoter: Functional analysis of a G-C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci 1991;88:11495-11499.
36. Bussenmakers MJG, Giroldi LA, van Bokhoven A, Schalken JA. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: Characterization of the human E-cadherin gene promoter. Biochem Biophys Res Commun 1994;203:1284-1290.
37. Takayama T, Shiozaki H, Inoue M, et al. Expression of E-cadherin and α-catenin molecules in human breast cancer tissues and associations with clinicopathological features. Int J Oncol 1994;5: 775-780.
38. Shiozaki H, Iihara K, Oka H, et al. Immunohistochemical detection of α-catenin expression in human cancers. Am J Pathol 1994;144:667-674.
39. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res 1993;53:3585-3590.
40. Shimoyama Y, Nagafuchi A, Fujita S, et al. Cadherin dysfunction in a human cancer cell line: Possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992;52:5770-5774.